Javascript must be enabled to continue!
QOL-18. Neuropsychological screening in a pediatric neuro-oncology multidisciplinary clinic.
View through CrossRef
Abstract
BACKGROUND: The purpose of this project was to examine the usefulness of neuropsychological screening in a multidisciplinary clinic for neuro-oncology populations and determine whether a brief evaluation can adequately screen children for cognitive dysfunction or psychiatric comorbidities. METHODS: Thirty-one children or young adults with a history of CNS tumor had neuropsychological screening as part of their multidisciplinary clinic visit. This screening evaluation consisted of clinical interview, neuropsychological testing, and the completion of emotional/behavioral checklists. Our neuropsychological test battery included the Kaufman Brief Intelligence Test-Second Edition (KBIT-2) and the NIH Toolbox Fluid Cognition Composite, which consists of 6 subtests - flanker task, working memory, processing speed, oral reading, card sort, and memory. RESULTS: Over a 15-month period 31 children, adolescents, and young adults with CNS tumors were seen in our neuropsychology screening clinic. Females made up 39% of the sample. The average age was 12.7 years (range=5–24 years). The average time to complete neuropsychological testing was 60.3 minutes. Thirty-six percent did not have any new neuropsychological diagnoses, 42% had one new diagnosis, 19% had two new diagnoses, and 3% had three new diagnoses. The most common new diagnoses were mild or major neurocognitive disorder (mild=29%, major=6%), anxiety (32%), ADHD (10%), and mood disorder (13%). Neurocognitive test scores were mostly in the average range (Verbal-IQ=97.7; Nonverbal-IQ=95.3; Total IQ=96.2; Flanker T-Score=46.1; Working Memory T-Score=44.0; Card Sort T-Score=43.7; Picture Memory T-Score=48.5). Processing speed and fluid cognition composite scores for the group were in the low-average range (Processing Speed T-Score=42.7; Fluid Cognition Composite T-Score=41.4). Behavioral health recommendations were needed for 71% of this sample. Educational recommendations were needed for 58%. CONCLUSIONS: Brief neuropsychological screening completed as part of multidisciplinary clinics for pediatric neuro-oncology patients was efficient and useful in identifying neuropsychological diagnoses in children and assisted with informing necessary behavioral health and academic interventions.
Oxford University Press (OUP)
Title: QOL-18. Neuropsychological screening in a pediatric neuro-oncology multidisciplinary clinic.
Description:
Abstract
BACKGROUND: The purpose of this project was to examine the usefulness of neuropsychological screening in a multidisciplinary clinic for neuro-oncology populations and determine whether a brief evaluation can adequately screen children for cognitive dysfunction or psychiatric comorbidities.
METHODS: Thirty-one children or young adults with a history of CNS tumor had neuropsychological screening as part of their multidisciplinary clinic visit.
This screening evaluation consisted of clinical interview, neuropsychological testing, and the completion of emotional/behavioral checklists.
Our neuropsychological test battery included the Kaufman Brief Intelligence Test-Second Edition (KBIT-2) and the NIH Toolbox Fluid Cognition Composite, which consists of 6 subtests - flanker task, working memory, processing speed, oral reading, card sort, and memory.
RESULTS: Over a 15-month period 31 children, adolescents, and young adults with CNS tumors were seen in our neuropsychology screening clinic.
Females made up 39% of the sample.
The average age was 12.
7 years (range=5–24 years).
The average time to complete neuropsychological testing was 60.
3 minutes.
Thirty-six percent did not have any new neuropsychological diagnoses, 42% had one new diagnosis, 19% had two new diagnoses, and 3% had three new diagnoses.
The most common new diagnoses were mild or major neurocognitive disorder (mild=29%, major=6%), anxiety (32%), ADHD (10%), and mood disorder (13%).
Neurocognitive test scores were mostly in the average range (Verbal-IQ=97.
7; Nonverbal-IQ=95.
3; Total IQ=96.
2; Flanker T-Score=46.
1; Working Memory T-Score=44.
0; Card Sort T-Score=43.
7; Picture Memory T-Score=48.
5).
Processing speed and fluid cognition composite scores for the group were in the low-average range (Processing Speed T-Score=42.
7; Fluid Cognition Composite T-Score=41.
4).
Behavioral health recommendations were needed for 71% of this sample.
Educational recommendations were needed for 58%.
CONCLUSIONS: Brief neuropsychological screening completed as part of multidisciplinary clinics for pediatric neuro-oncology patients was efficient and useful in identifying neuropsychological diagnoses in children and assisted with informing necessary behavioral health and academic interventions.
Related Results
Quality of life and factors associated with a good quality of life among diabetes mellitus patients in northern Thailand
Quality of life and factors associated with a good quality of life among diabetes mellitus patients in northern Thailand
Abstract
Background
Quality of life (QOL) is a good indicator of lifespan, especially for individuals who are suffering from a particular illness. Q...
The Pediatric Anesthesiology Workforce: Projecting Supply and Trends 2015–2035
The Pediatric Anesthesiology Workforce: Projecting Supply and Trends 2015–2035
BACKGROUND:
A workforce analysis was conducted to predict whether the projected future supply of pediatric anesthesiologists is balanced with the requirements of the in...
The Geographic Distribution of Pediatric Anesthesiologists Relative to the US Pediatric Population
The Geographic Distribution of Pediatric Anesthesiologists Relative to the US Pediatric Population
BACKGROUND:
The geographic relationship between pediatric anesthesiologists and the pediatric population has potentially important clinical and policy implications. In ...
Preference-Based Quality of Life in Patients With Cerebral Aneurysms
Preference-Based Quality of Life in Patients With Cerebral Aneurysms
Background and Purpose—
Functional outcome scales are typically used to measure quality of life (QOL) and outcomes in patients with cerebral aneurysms; how...
Patient-centered perspectives: Examining quality-of-life integration in phase III lung cancer trials (2019-2023).
Patient-centered perspectives: Examining quality-of-life integration in phase III lung cancer trials (2019-2023).
e23181 Background: In the dynamic landscape of lung cancer treatment, marked by precision medicine advancements, addressing the persistent global health challenge of lung cancer r...
A-48 The Relationship Between Concussion History and Emotional and Behavioral Dyscontrol Domains of Health-Related Quality of Life in College-Aged Individuals
A-48 The Relationship Between Concussion History and Emotional and Behavioral Dyscontrol Domains of Health-Related Quality of Life in College-Aged Individuals
Abstract
Purpose: The purpose of this study was to determine the relationship between concussion history and emotional and behavioral dyscontrol domains of health-re...
P071 Quality of life of patients treated in an Inflammatory Bowel Disease Program in Chile
P071 Quality of life of patients treated in an Inflammatory Bowel Disease Program in Chile
BACKGROUND:
Inflammatory Bowel Disease impacts patient's quality of life (QoL). Its chronic nature, flares, extraintestinal manifestations, the risk of surgery and canc...
Relationship of Self Efficacy in Medication Understanding with Quality of Life among Elderly with Type 2 Diabetes Mellitus on Polypharmacy in Malaysia
Relationship of Self Efficacy in Medication Understanding with Quality of Life among Elderly with Type 2 Diabetes Mellitus on Polypharmacy in Malaysia
Self-efficacy (SE) has been shown to be positively correlated with quality of life (QOL) among patients with type 2 diabetes mellitus (T2DM). Medication understanding (MU) on the o...

